Physician
Hematology
Dr. Sreenivasa R. Nattam, MD
|
|
Give Review
Sreenivasa Nattam works in the field of Hematology. He went to Sri Venkatesvara Medical College NTR. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Dr. Sreenivasa R. Nattam is also published. He has 18 publications published. The lastest publication: "The use of lumpectomy and radiation therapy instead of mastectomy for the primary management of carcinoma of the breast.' Sreenivasa Nattam is registered with Medicare and accepts Medicare payments.
Publications
- Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Grou...
- Treatment of elderly non-small cell lung Cancer patients with three different schedules of weekly paclitaxel in combination with carboplatin: subanalysis of a randomiz...
- Multicenter, randomized trial for stage IIIB or IV non-small-cell lung Cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or obse...
- A phase II trial of the epothilone B analog, BMS-247550, in patients with previously treated advanced colorectal Cancer.
- Gemcitabine, paclitaxel, and trastuzumab in metastatic breast Cancer.
- High-dose cimetidine for the treatment of metastatic renal Cell carcinoma. A Hoosier Oncology Group study.
- Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75.
- Randomized, double-blinded, multicenter, phase II study of pemetrexed, carboplatin, and bevacizumab with enzastaurin or placebo in chemonaïve patients with stage IIIB/...
- Gemcitabine plus sorafenib in patients with advanced pancreatic Cancer: a phase II trial of the University of Chicago Phase II Consortium.
- Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic Leukemia: final report of Cancer and Leukemia Group B study 19901.
- Pemetrexed plus cetuximab in patients with recurrent non-small cell lung Cancer (NSCLC): a phase I/II study from the Hoosier Oncology Group.
- Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-Cell carcinoma of the head and neck: a phase I/II study.
- Arsenic trioxide in patients with adenoCarcinoma of the pancreas refractory to gemcitabine: a phase II trial of the University of Chicago Phase II Consortium.
- Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803).
- Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-Cell lu...
- Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic Cancer.
- The use of lumpectomy and radiation therapy instead of mastectomy for the primary management of Carcinoma of the breast.
Schools
Sri Venkateswara Medical College Ntr University Of Health Sciences
Columbus Cuneo Cabrini Center
Ill Masonic Med Center
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Advocate Illinois Masonic Medical Center -
Sri Venkatesvara Medical College NTR
Drug Facts
| NPI NUMBER | 1982606893 | |
| NPPES Provider LastName | NATTAM | |
| NPPES Provider FirstName | SREENIVASA | |
| NPPES Provider ZIPCode | 468451727 | |
| NPPES Provider State | IN | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 1645.0 | |
| Distinct Opioid Count | 8.0 | |
| Opioid Claim Count | 246.0 | |
| Percent Opioid Claims | 14.95 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982606893 |
| Last Name Of The Provider | NATTAM |
| First Name Of The Provider | SREENIVASA |
| View All |
Similar Doctors
|
|
Dr. David M. Zimmerman, MD |
|
|
Dr. Gary R. Gize, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles J. Whalen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steve N. Rhinehart, MD |
|
|
Dr. Farrukh M. Adhami, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Praveen Kollipara, MD
This Doctor is OpenDoctor Recommended.
|